Predictors of early discontinuation and therapeutic response to anamorelin in patients with cancer cachexia: A retrospective study
Int. Journal of Clinical Pharmacology and Therapeutics · 01.10.2026 · 64 (10) · 526-536
DOI: 10.5414/cp204997 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.10.2026. Verfasst von Katsuyuki Takahashi und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Cachexia, Neoplasms, Oligopeptides, Hydrazines.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Takahashi, K., Abe, M., Yamase, H., Yoshino, H., Tsujii, K., Komatsu, Y., Otori, T., & Kobayashi, M. (2026). Predictors of early discontinuation and therapeutic response to anamorelin in patients with cancer cachexia: A retrospective study. Int. Journal of Clinical Pharmacology and Therapeutics, 64(10), 526-536. https://doi.org/10.5414/cp204997
Vancouver
Takahashi K, Abe M, Yamase H, Yoshino H, Tsujii K, Komatsu Y, et al. Predictors of early discontinuation and therapeutic response to anamorelin in patients with cancer cachexia: A retrospective study. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(10):526-536. doi:10.5414/cp204997
BibTeX
@article{Takahashi2026,
author = {Takahashi, Katsuyuki and Abe, Minami and Yamase, Hirotake and Yoshino, Hideki and Tsujii, Kayo and Komatsu, Yuika and Otori, Toru and Kobayashi, Masahiko},
title = {Predictors of early discontinuation and therapeutic response to anamorelin in patients with cancer cachexia: A retrospective study},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {64},
number = {10},
pages = {526--536},
doi = {10.5414/cp204997}
}
EUVIMED